Novel Oral Polio Vaccine Type 2 (nOPV2)-Video
"To end polio, we need to stop all types of the virus. Novel oral polio vaccine type 2 (nOPV2) is an improved vaccine for stopping outbreaks of circulating vaccine-derived poliovirus type 2 (cVDPV2). Learn more about cVDPV2 and the potential of nOPV2 for outbreak response."
"Untold Story About Black Children Who Had Polio and Were Treated.” (Video)
“Tuskegee University's critical role in treating Black children with polio and the first vaccine at the height of segregation." From ABC News
A Day in the Life of Frontline Health Workers (Video)
"From preparing coolers with vaccines to collecting and utilizing data to adjust the strategy of vaccination campaigns, these centers serve as a critical community hub in our efforts to end polio."
Hidden Figures in Polio History
“From 1940-1958, The Infantile Paralysis Center was housed on the campus of the Tuskegee Institute, known today as Tuskegee University. This red brick building in the South became the only place in the United States built specifically to treat Black children with polio. . . But the story doesn't end there."
Every Vaccine Counts
Every child that is vaccinated against polio brings us closer to eradication.
These are some of the ways children receive their polio vaccines.